What are a contracting officer's obligations under the BioPreferred mandate?

Under Section 9002 and FAR 23.103, federal buyers must include FAR 52.223-1 and 52.223-2 in solicitations for designated categories, give preference to biobased products, and document rationale if selecting non-biobased alternatives. Three narrow exceptions exist for cost, performance, and availability.

Biobased cleaning products with botanical ingredients on a polished surface

Execution Playbook9 min read

BioPreferred Procurement: The Complete Federal Buyer's Guide

The USDA BioPreferred Program requires federal agencies to purchase biobased products in 139 designated categories. Most COs do not know which of their purchases are covered. Here is the practical framework for compliance.

Michael FewFounder, Patriot Bio Supply

March 10, 2026

BioPreferredFAR 23.1USDACompliance

The BioPreferred mandate is not a guideline. It is a statutory requirement under Section 9002 of the Farm Security and Rural Investment Act, implemented through FAR 23.103. Every federal agency and every contractor operating a federal facility must give preference to biobased products in 139 USDA-designated categories.

The compliance gap is enormous. A 2024 GAO review found that fewer than 40% of federal purchase actions in designated categories included biobased alternatives. That is not noncompliance by intent. Most contracting officers and GPC cardholders do not know which products on their standing orders fall under the mandate. The catalog they order from does not flag BioPreferred categories. The compliance check happens at audit time, not at purchase time.

For COs managing facility procurement, the question is not whether the mandate applies. It does. The question is how to comply without adding hours to every purchase action.

What the Mandate Requires at the Transaction Level

For every procurement touching a designated category, two FAR clauses apply. 52.223-1 requires the vendor to certify biobased content. 52.223-2 requires the agency to give affirmative preference to biobased products. If a CO selects a non-biobased product, the contract file needs documented rationale -- not a checkbox, but a written justification.

The three statutory exceptions exist, but they are narrow:

The cost exception requires a side-by-side price comparison showing the biobased product is unreasonably more expensive. A one-line note does not hold up in a compliance review. The CO needs vendor quotes showing the specific price differential for the specific requirement.

The performance exception requires documented evidence -- test results or specification analysis -- showing the biobased product cannot meet the technical need. An assumption that biobased products perform worse is not documentation.

The unavailability exception requires proof that no biobased product exists in the needed quantity, timeline, or geography. In cleaning products and lubricants, this exception rarely applies because dozens of certified manufacturers supply the federal market.

The Categories That Generate the Most Audit Findings

General purpose cleaners are the highest-spend designated category and the most common audit flag. Facilities reorder the same products monthly without checking BioPreferred availability. Floor care products -- strippers, finishers, maintainers -- are the second most common gap. Facilities that have used the same floor care line for years rarely evaluate biobased alternatives unless prompted.

Less obvious categories catch facility managers off guard: lubricants for maintenance equipment, adhesive removers, metalworking fluids, and dust suppressants. These are purchased infrequently and outside the normal cleaning supply workflow, which means they bypass whatever BioPreferred awareness the purchasing team has built.

The practical solution is a product-level audit: map every recurring SKU to its USDA product category, identify which purchases fall in designated categories, and flag them for BioPreferred sourcing. A single audit at the facility level takes a few hours and eliminates the most common compliance gaps before they become findings.

What the Mandate Requires at the Transaction Level

The Categories That Generate the Most Audit Findings

Related Insights

Manufacturer's Guide: Getting Your Products Into the Federal BioPreferred Channel

Prime Contractor's Playbook: Meeting Small Business Subcontracting Goals Without the Scramble

BioPreferred Category Mandate: What Federal Buyers Need to Know in 2026